Properly structured and implemented, diagnostic patent pools could integrate complementary technologies, reduce transaction costs and spur innovation.
Genetic diseases often involve multiple genes and/or gene fragments that are patented, along with diagnostic methods and microprocessing arrays. Potential roadblocks to the accessibility of present and new genetic testing technologies can result from (i) patentees exercising their right to exclude the use of their patented technology by anyone other than themselves or their exclusive licensee ('exclusivity')1 and (ii) the need to acquire multiple licenses to an ever increasing number of patents owned by different patentees.
URL (Nature Biotechnology)
Genetic diseases, Licenses, Patentees, Patents
|Authors||Ebersole, Ted J. (Sterne Kessler Goldstein & Fox PLLC, Washington DC, USA), Guthrie, Marvin C. (Sterne Kessler Goldstein & Fox PLLC, Washington DC, USA), Goldstein, Jorge A. (Sterne Kessler Goldstein & Fox PLLC, Washington DC, USA)|
|Keywords:||Genetic diseases, Licenses, Patentees, Patents|